These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32626839)

  • 21. Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma.
    Sircana A; Paschetta E; Saba F; Molinaro F; Musso G
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30970564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigating Nonalcoholic Fatty Liver Disease in a Liver-on-a-Chip Microfluidic Device.
    Gori M; Simonelli MC; Giannitelli SM; Businaro L; Trombetta M; Rainer A
    PLoS One; 2016; 11(7):e0159729. PubMed ID: 27438262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications.
    Hydes T; Brown E; Hamid A; Bateman AC; Cuthbertson DJ
    Clin Ther; 2021 Sep; 43(9):1505-1522. PubMed ID: 34400007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How to Face Chronic Liver Disease: The Sinusoidal Perspective.
    Fernández-Iglesias A; Gracia-Sancho J
    Front Med (Lausanne); 2017; 4():7. PubMed ID: 28239607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma.
    Alqahtani SA; Chan WK; Yu ML
    Clin Liver Dis; 2023 May; 27(2):211-223. PubMed ID: 37024203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease.
    Jiao J; Sanchez JI; Saldarriaga OA; Solis LM; Tweardy DJ; Maru DM; Stevenson HL; Beretta L
    JHEP Rep; 2023 Feb; 5(2):100628. PubMed ID: 36687470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Research progress of hepatic non-parenchymal cells in nonalcoholic steatohepatitis].
    Zheng TX; Li R; Tan P; Huang MZ; Qian BL; Chen H; Fu WW
    Zhonghua Gan Zang Bing Za Zhi; 2021 Jul; 29(7):711-715. PubMed ID: 34371545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formation of superoxide anion in the hepatic sinusoid after lipopolysaccharide challenge.
    Yokoyama H; Mizukami T; Kamegaya Y; Fukuda M; Okamura Y; Matsumoto M; Kato S; Ishii H
    Alcohol Clin Exp Res; 1998 May; 22(S3 Pt 1):133S-136S. PubMed ID: 9622390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chlorogenic acid alleviated liver fibrosis in methionine and choline deficient diet-induced nonalcoholic steatohepatitis in mice and its mechanism.
    Miao H; Ouyang H; Guo Q; Wei M; Lu B; Kai G; Ji L
    J Nutr Biochem; 2022 Aug; 106():109020. PubMed ID: 35472433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Crosstalk Between Liver Sinusoidal Endothelial Cells and Hepatic Microenvironment in NASH Related Liver Fibrosis.
    Du W; Wang L
    Front Immunol; 2022; 13():936196. PubMed ID: 35837401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levistilide A inhibits angiogenesis in liver fibrosis via vascular endothelial growth factor signaling pathway.
    Zhao ZM; Liu HL; Sun X; Guo T; Shen L; Tao YY; Liu CH
    Exp Biol Med (Maywood); 2017 May; 242(9):974-985. PubMed ID: 28440736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single cell-resolved study of advanced murine MASH reveals a homeostatic pericyte signaling module.
    Bendixen SM; Jakobsgaard PR; Hansen D; Hejn KH; Terkelsen MK; Bjerre FA; Thulesen AP; Eriksen NG; Hallenborg P; Geng Y; Dam TV; Larsen FT; Wernberg CW; Vijayathurai J; Scott EAH; Marcher AB; Detlefsen S; Grøntved L; Dimke H; Berdeaux R; de Aguiar Vallim TQ; Olinga P; Lauridsen MM; Krag A; Blagoev B; Ravnskjaer K
    J Hepatol; 2024 Mar; 80(3):467-481. PubMed ID: 37972658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Vitro Models for the Study of Liver Biology and Diseases: Advances and Limitations.
    Kaur S; Kidambi S; Ortega-Ribera M; Thuy LTT; Nieto N; Cogger VC; Xie WF; Tacke F; Gracia-Sancho J
    Cell Mol Gastroenterol Hepatol; 2023; 15(3):559-571. PubMed ID: 36442812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhibition of Group IVA Phospholipase A
    Akiba S; Kawashita E; Ishihara K
    Yakugaku Zasshi; 2019; 139(9):1155-1162. PubMed ID: 31474631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. JAM-A is a multifaceted regulator in hepatic fibrogenesis, supporting LSEC integrity and stellate cell quiescence.
    Brozat JF; Brandt EF; Stark M; Fischer P; Wirtz TH; Flaßhove A; Rodenhausen AN; Vajen T; Heinzmann ACA; Schmitz SM; Abu Jhaisha S; Röth AA; Koenen RR; Sahin H; Trautwein C; Berres ML
    Liver Int; 2022 May; 42(5):1185-1203. PubMed ID: 35129269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonalcoholic steatohepatitis and hepatocellular carcinoma: Brazilian survey.
    Cotrim HP; Oliveira CP; Coelho HS; Alvares-da-Silva MR; Nabuco L; Parise ER; Ivantes C; Martinelli AL; Galizzi-Filho J; Carrilho FJ
    Clinics (Sao Paulo); 2016 May; 71(5):281-4. PubMed ID: 27276398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic Stellate Cell-Immune Interactions in NASH.
    Carter JK; Friedman SL
    Front Endocrinol (Lausanne); 2022; 13():867940. PubMed ID: 35757404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reprogramming of Hepatic Metabolism and Microenvironment in Nonalcoholic Steatohepatitis.
    Rui L; Lin JD
    Annu Rev Nutr; 2022 Aug; 42():91-113. PubMed ID: 35584814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.
    Kanda T; Goto T; Hirotsu Y; Masuzaki R; Moriyama M; Omata M
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose- and time-dependent effects of ethanol on functional and structural aspects of the liver sinusoid in the mouse.
    Sarphie G; D'Souza NB; Van Thiel DH; Hill D; McClain CJ; Deaciuc IV
    Alcohol Clin Exp Res; 1997 Sep; 21(6):1128-36. PubMed ID: 9309327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.